We are live on ! Find out more
HF

HRT Financial Portfolio holdings

AUM $40.1B
1-Year Est. Return 58.22%
This Fund
S&P 500
This Quarter Est. Return
+7.61%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.81%
AUM
$10.9B
AUM Growth
+$1.02B
Cap. Flow
+$744M
Cap. Flow %
6.82%
Top 10 Hldgs %
30.62%
Holding
3,895
New
1,275
Increased
565
Reduced
595
Closed
1,134

Sector Composition

Rank Sector Weight
1 Technology 9.66%
2 Healthcare 9.21%
3 Consumer Discretionary 8.28%
4 Industrials 6.28%
5 Materials 5.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SDAC
2376
DELISTED
Sustainable Development Acquisition I Corp. Class A Common Stock
SDAC
$204K ﹤0.01%
+21,117
New +$206K
LIT icon
2377
Global X Lithium & Battery Tech ETF
LIT
$1.56B
$203K ﹤0.01%
+2,815
New +$181K
CRUS icon
2378
Cirrus Logic
CRUS
$6.19B
$202K ﹤0.01%
+2,379
New +$191K
DAVA icon
2379
Endava
DAVA
$154M
$202K ﹤0.01%
+1,790
New +$173K
SBCF icon
2380
Seacoast Banking Corp of Florida
SBCF
$3.34B
$202K ﹤0.01%
+5,928
New +$216K
CRSR icon
2381
Corsair Gaming
CRSR
$1.13B
$201K ﹤0.01%
+6,053
New +$199K
GTPAU
2382
DELISTED
Gores Technology Partners, Inc. Units
GTPAU
$201K ﹤0.01%
19,732
LOGC
2383
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$201K ﹤0.01%
+45,397
New +$231K
CX icon
2384
Cemex
CX
$16.3B
$200K ﹤0.01%
23,914
-52,879
-69% -$420K
MBCN
2385
DELISTED
Middlefield Banc Corp
MBCN
$200K ﹤0.01%
+8,500
New +$194K
NMRD
2386
DELISTED
Nemaura Medical, Inc. Common Stock
NMRD
$200K ﹤0.01%
+19,418
New +$185K
HIMX
2387
Himax Technologies
HIMX
$2.4B
$199K ﹤0.01%
11,966
-3,432
-22% -$45.3K
SSRM icon
2388
SSR Mining
SSRM
$5.87B
$199K ﹤0.01%
+12,799
New +$215K
TRAK icon
2389
ReposiTrak
TRAK
$158M
$199K ﹤0.01%
+36,286
New +$206K
HT
2390
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$199K ﹤0.01%
+18,525
New +$205K
AQST icon
2391
Aquestive Therapeutics
AQST
$492M
$198K ﹤0.01%
+49,907
New +$199K
BELFB
2392
Bel Fuse Inc Class B
BELFB
$4.18B
$198K ﹤0.01%
+13,799
New +$227K
EOSEW
2393
Eos Energy Enterprises Warrant
EOSEW
$31.7M
$198K ﹤0.01%
27,549
-810
-3% -$5.3K
ENFY
2394
DELISTED
Enlightify Inc
ENFY
$198K ﹤0.01%
20,018
-700
-3% -$8.28K
CALB
2395
DELISTED
California BanCorp Common Stock
CALB
$198K ﹤0.01%
+10,600
New +$190K
FTPAU
2396
DELISTED
FTAC Parnassus Acquisition Corp. Unit
FTPAU
$198K ﹤0.01%
19,396
-1,800
-8% -$18.2K
PTRAW
2397
DELISTED
Proterra Inc. Warrant
PTRAW
$198K ﹤0.01%
35,355
-15,877
-31% -$83.5K
MOR
2398
DELISTED
MorphoSys AG American Depositary Shares
MOR
$197K ﹤0.01%
+10,253
New +$219K
DYAI icon
2399
Dyadic International
DYAI
$37.2M
$196K ﹤0.01%
+54,700
New +$229K
ZYNE
2400
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$196K ﹤0.01%
37,239
-26,476
-42% -$127K

Similar funds

HRT Financial's Q2 2021 Portfolio in Review

As of Q2 2021, HRT Financial held 3,895 positions worth $10.9B, up 10% from $9.88B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

HRT Financial deployed $744M of net new capital in Q2 2021, opening 1,275 new positions and adding to 565 existing holdings. Its largest new stake was Linde: 872,603 shares worth $252M.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.1% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $330M trimmed.

  • HRT Financial's largest Q2 2021 buy was Linde: 872,603 shares worth $252M.
  • HRT Financial added most to Invesco QQQ Trust in Q2 2021, an estimated $289M increase.
  • HRT Financial's biggest Q2 2021 reduction was iShares Russell 2000 ETF, cutting an estimated $330M.
  • HRT Financial fully exited Palantir in Q2 2021, selling an estimated $130M.
  • HRT Financial's ten largest holdings make up 31% of its $10.9B portfolio in Q2 2021.
  • HRT Financial opened 1,275 new positions and closed 1,134 in Q2 2021.
  • HRT Financial's portfolio value rose 10% quarter-over-quarter to $10.9B.

Based on HRT Financial's 13F filing for Q2 2021, filed 16 Aug 2021.